T. C. Johnson et al. / Bioorg. Med. Chem. 17 (2009) 4230–4240
4235
C14H15N5O5S: C, 46.02; H, 4.14; N, 19.17; S 8.77. Found: C, 46.17; H,
4.00; N, 19.00; S, 8.99.
1H), 7.58–7.54 (m, 3H), 4.85–4.69 (dt, J = 3.8, 47.7 Hz, 2H), 4.44–
4.34 (dt, J = 3.8, 30.0 Hz, 2H), 4.02 (s, 3H), 3.82 (s, 3H); 13C NMR
(DMSO-d6), d 164.4, 158.3, 154.0, 147.9, 146.6, 146.1, 143.7,
141.5, 139.2, 131.1, 124.3, 123.9, 122.0, 118.3, 57.1, 55.8, 53.4;
MS-DIP (CI) m/z 465 ([M]+). Anal. Calcd for C16H15F4N5O5S: C
41.29; H, 3.25; N, 15.05; S, 6.89. Found: C, 41.35; H, 3.09; N,
14.89; S, 6.94.
3.1.9. 2-Trifluoromethyl-N-(5,8-dimethoxy-1,2,4-triazolo[1,5-
c]pyrimidin-2-yl)benzenesulfonamide (6i)
The product was isolated as a white powder (20% yield): mp
189–191 °C; 1H NMR (DMSO-d6) d 12.4 (br s, 1H), 8.32 (d,
J = 7.3 Hz, 1H), 8.00 (d, J = 7.9 Hz, 1H), 7.91–7.86 (m, 2H), 7.61 (s,
1 H), 4.07 (s, 3H), 3.88 (s, 3H).
3.1.16. 2-(3-Fluoropropoxy)-6-trifluoromethyl-N-(5,8-
dimethoxy-1,2,4-triazolo[1,5-c]pyrimidin-2-
3.1.10. 2,5-Dichloro-N-(5,8-dimethoxy-1,2,4-triazolo[1,5-c]
pyrimidin-2-yl)benzenesulfonamide (6j)
yl)benzenesulfonamide (6p)
The product was isolated as a tan solid (30% yield): mp 210–
212 °C; 1H NMR (DMSO-d6) d 11.79 (s, 1H), 7.72 (t, J = 8.1 Hz,
1H), 7.56–7.52 (m, 3H), 4.56 (dt, J = 5.8, 47.5 Hz, 2H), 4.19 (t,
J = 5.8 Hz, 2H), 4.02 (s, 3H), 3.83 (s, 3H), 2.12 (dp, J = 5.8, 26.1 Hz,
2H); LC–MS (ESI) m/z 480 ([M+H]+). Anal. Calcd for C17H17F4N5O5S:
C, 42.57; H, 3.57; N, 14.61; S, 6.69. Found: C, 42.48; H, 3.53; N,
14.42; S, 6.57.
The product was isolated as a white solid (62% yield): mp 219–
221 °C; 1H NMR (DMSO-d6) d 12.70 (br s, 1H), 8.16 (s, 1H), 7.79–
7.60 (m, 3H), 4.08 (s, 3H), 3.90 (s, 3H); 13C NMR (DMSO-d6) d
157.6, 148.1, 143.8, 139.3, 138.4, 134.5, 133.4, 131.8, 131.6,
129.6, 124.3, 57.2, 55.8; MS-DIP (CI) m/z 404 ([M]+). Anal. Calcd
for C13H11Cl2N5O4S: C, 38.63; H, 2.74; N, 17.33; S, 7.93. Found: C,
38.60; H, 2.85; N, 17.35; S, 8.13.
3.1.17. 2-(2,2,2-Trifluoroethoxy)-6-trifluoromethyl-N-(5,8-
dimethoxy-1,2,4-triazolo[1,5-c]pyrimidin-2-
yl)benzenesulfonamide (6q)
3.1.11. 3,5-Dichloro-N-(5,8-dimethoxy-1,2,4-triazolo[1,5-
c]pyrimidin-2-yl)benzenesulfonamide (6k)
The product was isolated as a white solid (34% yield): mp 195–
197 °C; 1H NMR (DMSO-d6) d 12.80 (br s, 1H), 8.01 (s, 1H), 7.99 (s,
2H), 7.65 (s, 1H), 4.12 (s, 3H), 3.93 (s, 3H); 13C NMR (DMSO-d6) d
157.9, 148.1, 144.0, 142.7, 139.4, 134.8, 133.0, 125.9, 124.2, 57.3,
55.9; MS-DIP (CI) m/z 404 ([M]+). Anal. Calcd for C13H11Cl2N5O4S:
C, 38.63; H, 2.74; N, 17.33; S, 7.93. Found: C, 38.80; H, 2.68; N,
17.09; S, 7.78.
The product was isolated as a white solid (30% yield): mp 211–
213 °C; 1H NMR (DMSO-d6) d 11.87 (s, 1H), 7.80 (t, J = 8.5 Hz, 1H),
7.67 (d, J = 7.9 Hz, 2H), 7.57 (s, 1H), 4.94 (q, J = 8.8 Hz, 2H), 4.04 (s,
3H), 3.83 (s, 3H); LC–MS (ESI) m/z 500 ([MÀH]À). Anal. Calcd for
C16H13F6N5O5S: C, 38.33; H, 2.61; N, 13.97; S, 6.39. Found: C,
38.26; H, 2.59; N, 13.89; S, 6.40.
3.1.18. 2-(2,2-Difluoroethoxy)-6-trifluoromethyl-N-(5,8-
dimethoxy-1,2,4-triazolo[1,5-c]pyrimidin-2-
yl)benzenesulfonamide (6r)
3.1.12. 2,6-Dimethoxy-N-(5,8-dimethoxy-1,2,4-triazolo[1,5-
c]pyrimidin-2-yl)-benzenesulfonamide (6l)
The product was isolated as an off-white solid (68% yield): mp
239–240 °C; 1H NMR (DMSO-d6) d 11.54 (s, 1H), 7.55 (s, 1H),
7.44 (t, J = 8.4 Hz, 1H), 6.74 (d, J = 8.4 Hz, 2H), 4.06 (s, 3H), 3.88
(s, 3H), 3.76 (s, 6H); 13C NMR (DMSO-d6) d 159.2, 158.4, 148.0,
143.7, 139.3, 134.1, 123.3, 117.3, 105.5, 57.0, 56.6, 55.7. Anal. Calcd
for C15H17N5O6S: C, 45.57; H, 4.33; N, 17.71; S, 8.11. Found: C,
45.47; H, 4.34; N, 17.54; S, 8.09.
The product was isolated as a tan solid (24% yield): mp 223–
224 °C; 1H NMR (DMSO-d6) d 11.89 (s, 1H), 7.76 (t, J = 8.2 Hz,
1H), 7.62 (m, 3H), 6.50 (tt, J = 4.2, 54.9 Hz, 1H), 4.48 (td, J =
3.8, 13.7 Hz, 2H), 4.03 (s, 3H), 3.83 (s, 3H); LC–MS (ESI) m/z
482 ([MÀH]À). Anal. Calcd for C16H14F5N5O5S: C, 39.76; H,
2.92; N, 14.49; S, 6.63. Found: C, 39.52; H, 2.74; N, 14.27; S,
6.82.
3.1.13. 2-Methoxy-6-trifluoromethyl-N-(5,8-dimethoxy-1,2,4-
triazolo[1,5-c]pyrimidin-2-yl)-benzenesulfonamide (6m)
The product was isolated as a white solid (29% yield): mp 238–
240 °C; 1H NMR (DMSO-d6) d 11.87 (s, 1H), 7.74 (t, J = 8.1, 8.4 Hz,
1H), 7.56–7.51 (m, 3H), 4.05 (s, 3H), 3.86 (s, 3H), 3.85 (s, 3H); 13C
NMR (DMSO-d6) d 158.3, 158.0, 148.1, 143.8, 139.3, 134.2, 129.6,
129.3, 129.0, 126.7, 126.8, 124.2, 123.9, 121.4, 119.54, 119.47,
118.2, 57.2, 55.8; MS-DIP (CI) m/z 434 ([M+1]+). Anal. Calcd for
C15H14F3N5O5S: C, 41.57; H, 3.26; N, 16.16; S, 7.40. Found: C,
41.46; H 3.20; N, 16.26; S, 7.34.
3.1.19. 1-[2-Fluoro-1-(fluoromethyl)ethoxy]-6-trifluoromethyl-
N-(5,8-dimethoxy-1,2,4-triazolo[1,5-c]pyrimidin-2-
yl)benzenesulfonamide (6s)
The product was isolated as a white solid (19% yield): mp 229–
231 °C; 1H NMR (DMSO-d6) d 11.81 (br s, 1H), 7.79–7.69 (m, 2H),
7.61–7.59 (m, 2H), 5.42–5.23 (m, 1H), 4.84–4.55 (m, 4H), 4.06 (s,
3H), 3.85 (s, 3H); LC–MS (ESI) m/z 498 ([MÀH]+). Anal. Calcd for
C17H16F5N5O5S: C, 41.05; H, 3.24; N, 14.08; S, 6.45. Found: C,
40.95; H, 3.12; N, 13.96; S, 6.57.
3.1.20. 2,6-Dichloro-N-(5,7-dimethoxy-1,2,4-triazolo[1,5-
c]pyrimidin-2-yl)benzenesulfonamide (7)
A round bottom flask was charged with 2,6-dichloro-N-(5-
methoxy-7-fluoro-1,2,4-triazolo[1,5-c]pyrimidin-2-yl)benzenesul-
fonamide (6g, 0.50 g, 1.3 mmol) and anhydrous MeOH (3 mL). To
3.1.14. 2-Ethoxy-6-trifluoromethyl-N-(5,8-dimethoxy-1,2,4-
triazolo[1,5-c]pyrimidin-2-yl)-benzenesulfonamide (6n)
The product was isolated as a white solid (29% yield): mp
232–234 °C (d); 1H NMR (DMSO-d6), d 11.8 (br s, 1H), 7.72 (t,
J = 8.3 Hz, 1H), 7.59 (s, 1H), 7.53 (d, J = 8.0 Hz, 2H), 4.23 (q,
J = 7.0 Hz, 2H), 4.06 (s, 3H), 3.86 (s, 3H), 1.20 (t, J = 7.0 Hz, 3H);
LC–MS (ESI) m/z 446 ([MÀH]À). Anal. Calcd for C16H16F3N5O5S:
C, 42.96; H, 3.60; N, 15.65; S, 7.17. Found: C, 42.85; H, 3.51;
N, 15.71; S, 7.24.
this mixture was added
a solution of sodium methoxide
(0.61 mL, 2.7 mmol, 25% in MeOH) at which time all the solids dis-
solved giving a dark solution. After 2 h, a solid had precipitated
from the solution. The mixture was stirred for 18 h, the reaction
quenched with HOAc (1 mL), and the methanol removed in vacuo
to give a tan solid. The crude material was purified by column
chromatography (SiO2, CH2Cl2/EtOH, 95:5) to afford 7 as a white
powder (0.30 g, 56% yield): mp 245–247 °C; 1H NMR (DMSO-d6)
d 12.6 (br s, 1H), 7.65–7.57 (m, 3H), 6.45 (s, 1H), 4.11 (s, 3H),
3.88 (s, 3H). Anal. Calcd for C13H11Cl2N5O4S: C, 38.63; H, 2.74; N,
17.33; S, 7.93. Found: C, 38.43; H, 2.75; N, 17.19; S, 8.09.
3.1.15. 2-(2-Fluoroethoxy)-6-trifluoromethyl-N-(5,8-
dimethoxy-1,2,4-triazolo[1,5-c]pyrimidin-2-
yl)benzenesulfonamide (6o)
The product was isolated as a white solid (52% yield): mp 233–
235 °C; 1H NMR (DMSO-d6) d 11.82 (br s, 1H), 7.72 (t, J = 8.0 Hz,